HIV DIAGNOSTICS TEST MARKET ANALYSIS

Regional Analysis

To learn more about this report, request sample copy

North America has remained the dominant region in the global HIV diagnostics test market over the past decade and is estimated to hold 37.9% of the market share in 2024. Strong presence of leading international players, high awareness levels regarding sexually transmitted infections (STI) diagnosis and favorable reimbursement policies have augmented the demand for HIV diagnostic tests in the country. Moreover, heavy investments by both public and private players to develop advanced testing methods have ensured steady supplier access to the latest products.

The HIV diagnostics test market in the Middle East & Africa region is anticipated to develop at the highest CAGR over the forecasted period attributed to increasing healthcare investment by local and foreign organizations. The antibody test subsegment currently holds the largest share of the by test type segment in the HIV diagnostics test market in the Middle East & Africa region. This is driven primarily by the high adoption of fourth generation antibody tests in the region over the past 2 years. Fourth generation antibody tests are now widely used for HIV screening across major healthcare facilities in South Africa, Nigeria and Ethiopia due to their ability to detect both anti-HIV antibodies and the HIV p24 antigen. This allows for a much earlier detection of the infection compared to previous generations of antibody tests. Several observational studies conducted by UNAIDS and country-specific health ministries have found that the increased use of fourth generation antibody tests has helped reduce new HIV infections in the region by making it possible to identify positive cases much sooner.